Koh Minji, Kim Young Seok, Ahn Hanjong, Kim Choung-Soo
Department of Radiation Oncology, Asan Medical Center, University of Ulsan, College of Medicine, Seoul, Republic of Korea.
Department of Radiation Oncology, Asan Medical Center, University of Ulsan, College of Medicine, Seoul, Republic of Korea
Anticancer Res. 2018 Nov;38(11):6579-6584. doi: 10.21873/anticanres.13025.
BACKGROUND/AIM: The efficacy of adjuvant or salvage radiation to the regional lymph node area has not been fully investigated in high-risk prostate cancer patients; instead, radiotherapy is limited to the prostate fossa. The present study aimed to assess patterns of recurrence in prostate cancer patients with biochemical failure (BCF) who were treated with whole-pelvic salvage radiotherapy (SRT) following radical prostatectomy.
The clinical data from 196 high-risk prostate cancer patients who received SRT for BCF after radical prostatectomy were reviewed. BCF after SRT was detected in 80 patients, and 59 patients underwent imaging studies.
Twenty four recurrences in 16 patients were identified, including 13 bone metastases, 6 vesicourethral anastomosis site recurrences, and 5 lymph node recurrences (one simultaneous with vesicourethral anastomosis). Regarding the treatment field, no in-field nodal recurrence was observed, whereas 4 out-of-field and 1 edge-of-field recurrences were detected.
Locoregional recurrence was most common at the anastomosis site. Most nodal recurrences were located outside the pelvis, suggesting that elective pelvic nodal irradiation should be recommended in a selected patient population.
背景/目的:高危前列腺癌患者区域淋巴结区域辅助放疗或挽救性放疗的疗效尚未得到充分研究;相反,放疗仅限于前列腺窝。本研究旨在评估根治性前列腺切除术后接受全盆腔挽救性放疗(SRT)的生化复发(BCF)前列腺癌患者的复发模式。
回顾了196例高危前列腺癌患者根治性前列腺切除术后因BCF接受SRT的临床资料。SRT后80例患者检测到BCF,59例患者接受了影像学检查。
16例患者出现24次复发,包括13例骨转移、6例膀胱尿道吻合口复发和5例淋巴结复发(1例与膀胱尿道吻合同时发生)。关于治疗区域,未观察到野内淋巴结复发,而检测到4例野外复发和1例野边缘复发。
局部区域复发最常见于吻合口部位。大多数淋巴结复发位于盆腔外,提示应在特定患者群体中推荐选择性盆腔淋巴结照射。